Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

GlaxoSmithKline and ViiV Healthcare present compounds for HIV infection

Feb. 25, 2020

New HDAC inhibitors disclosed by Merck & Co.

Feb. 20, 2020

TaiMed studies TMB-365 in first-in-human trial for HIV-1

Feb. 12, 2020

Newly identified HIV broadly neutralizing antibody is hard to escape

Feb. 11, 2020

HVTN702 HIV vaccine study stopped early due to non-efficacy

Feb. 4, 2020

Reservoir dogs don't hunt

Feb. 4, 2020

Researchers achieve the reversal of HIV and SIV latency in vivo

Jan. 27, 2020

DFH Therapeutics and HHS describe betulinic acid derivatives for HIV infection

Jan. 22, 2020

ViiV Healthcare UK patents HIV integrase inhibitors

Jan. 17, 2020

ViiV Healtcare's Dovato receives approval in Japan for HIV infection

Jan. 15, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...